ASSESSMENT OF DRUG-THERAPY AND HEALTH-RELATED QUALITY OF LIFE IN CANCER PATIENTS RECEIVING PHARMACEUTICAL CARE VERSUS USUAL CARE

Phase 1

Completed

• Conditions: cancer patients receiving chemotherapy; drug therapy related quality of life; pharmaceutical care; Pormpt-qol

• Registration Number: TCTR20210809008
• Lead Sponsor: /A

Brief Summary

Pharmaceutical care provision increased drug-therapy and health-related quality of life among cancer patients receiving chemotherapy more than usual care did. Achieving desired outcomes require both patient-centered care and a sensitive instrument.

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-02-28
• Study Start: 2021-08-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 237

Inclusion Criteria

Patients receiving treatment at the chemotherapy unit, Samutprakarn Hospital from November 2020 to Fabruary 2021.
Patients receiving chemotherapy drugs at every cycle except the last cycle.
18 years old or older.
Not disabled. No psychoactive symptoms. O Patients agree to participate in the study.

Exclusion Criteria

Patients referred to other hospitals
Patients loss follow-up
Patients death

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
drug therapy-related quality of life Before and after Independent t-test

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A